The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Atorvastatin 40 mg film-coated tablets

Sun Pharmaceutical Industries Europe B.V.PA2050/003/003

Main Information

Trade NameAtorvastatin 40 mg film-coated tablets
Active SubstancesAtorvastatin calcium trihydrate
Dosage FormFilm-coated tablet
Licence HolderSun Pharmaceutical Industries Europe B.V.
Licence NumberPA2050/003/003

Group Information

ATC CodeC10AA HMG CoA reductase inhibitors
C10AA05 atorvastatin


License statusAuthorised
Licence Issued07/09/2012
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0001-004-003
Interchangeable List DocumentPDF of Interchangeable List
« Back